US8440631 — Compositions for drug administration
Method of Use · Assigned to Aegis Therapeutics LLC · Expires 2026-05-09 · 0y expired
What this patent protects
This patent protects compositions that combine an alkyl glycoside with a therapeutic agent, such as a 5-HT receptor agonist, to increase bioavailability and provide migraine pain relief.
USPTO Abstract
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject, as well as compositions and methods for providing migraine pain relief. The compositions include at least one alkyl glycoside and at least one therapeutic agent, such as a 5-HT receptor agonist, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.
Drugs covered by this patent
- Imitrex (SUMATRIPTAN) · GSK
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1719 |
— | Imitrex |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.